生物医学传感器市场——增长、趋势、COVID-19 的影响、预测 (2023-2028)

生物医学传感器市场将在 2020 年达到 107.9 亿美元，并在 2026 年达到 151.3 亿美元，在预测期内 (2021-2026) 以 6% 的复合年增长率增长 据预测，

使用微技术和纳米技术的生物医学传感器领域的技术进步有望带来适用于单个基因产品的小型、坚固、智能且具有成本效益的传感器。 这些传感器可以设置为在您获得不可预测的读数时提醒您，筛查血液中是否存在有毒物质，或将药物直接输送到您的循环系统中。 对开发具有此类功能的传感器的投资预计将成为市场增长的关键因素，最终这些产品将在医疗保健行业产生巨大需求。

主要亮点

• 对患者监护应用的需求不断增长，MEMS 创新支持低成本、高性能传感器的设计，以及易于集成到其他应用中，这些都是市场增长的主要驱动力。 此外，生活方式病发病率上升、人口老龄化比例增加、疾病新形式等也对全球生物医学传感器市场增长起到重要作用。
• 生物传感器在纳米技术领域的新应用，以及导致基于传感器的创新型非侵入式医疗应用开发的持续创新，将为该市场开闢多个增长机会。 然而，与使用生物医学传感器相关的安全问题、较长的产品开发週期以及医疗领域运营所需的严格监管程序仍然是阻碍整体市场增长的主要挑战。
• 生物医学传感器在挽救生命的情况下发挥着重要作用，但由于强电磁场、从外部到内部组件的高效和高数据速率能量传输以及有限的市场，它在患者安全和舒适度方面受到限制面临先进计算和数据存储、超低功耗等挑战。

主要市场趋势

医疗保健行业在生物医学传感器市场中占有很大份额。

• 近年来，许多医疗保健研究人员越来越关注疾病的早期检测和预防。 传染病正在成为主要的死亡原因，尤其是对于新兴国家的人们而言，对这些疾病的早期检测和准确诊断是推动生物医学传感器市场发展的重要因素。
• 加速度计用于测量心率、血压、血糖和氧气水平。 这些传感器主要应用于除颤器和心臟起搏器等设备。 因此，医疗保健意识的提高推动了对传感器技术和监测设备的需求，这些设备可以感知健康状况并向用户提供反馈以提高安全性。
• 用于医疗保健的医疗传感器有可能彻底改变疾病的治疗和预防。 工程、技术和材料科学的进步使得拥有可用于医学研究的先进传感器成为可能。 此类传感器为技术创新打开了大门，有朝一日可能会导致针对瘫痪、截肢和其他运动障碍患者的思想控制假肢和其他个人辅助设备引领市场。

全球生物传感器市场以北美为主

• 由于医疗传感器供应商数量众多，北美是生物传感器市场的主要收入来源，预计会快速增长。 该市场增长的主要驱动力是北美人口迅速老龄化和不断增长的家庭保健市场。
• 美洲在 2018 年主导了全球市场，原因是该地区拥有先进的医疗基础设施和医疗设备的超常消费。 越来越多的智能手机和平板电脑用户证明了传感器、数字应用程序和无线技术的融合，为创新医疗产品的扩展留下了巨大空间。
• 许多公司都在研究这些产品，并且由于政府机构增加了资金，未来北美生物传感器市场将出现更先进和创新的产品，例如可穿戴设备和植入式传感器。生物传感器有望发布。 智能手机普及率的上升也推动了北美市场的增长，美国在该市场占据主导地位。

竞争格局

生物医学传感器市场竞争激烈，由多家大型企业组成。 从市场份额的角度来看，一些主要参与者目前主导着市场。 这些大公司专注于扩大海外客户群。 可支配收入的增加、对配备传感器的设备的认识不断提高以及全球客户群的扩大正在为市场参与者创造重要的增长机会。 这些参与者正在利用战略联合计划来增加市场份额和盈利能力。

• 2019 年 2 月 - 德州仪器 (TI) 宣布推出一款新的基于体声波 (BAW) 的嵌入式处理和模拟芯片，用于下一代连接和通信基础设施。 前两款采用 TI BAW 技术开发的器件，即 SimpleLink CC2652RB 无线微控制器 (MCU) 和 LMK05318 网络同步器时钟，可帮助系统设计人员简化设计物流以加快上市时间，从而实现稳定、简单和高性能的数据传输，进而有可能降低总体开发和系统成本。

其他好处

• Excel 格式的市场预测 (ME) 表
• 三个月的分析师支持

内容

第一章介绍

• 调查结果
• 调查假设
• 本次调查的范围

第二章研究方法论

第 3 章执行摘要

第四章市场动态

• 市场概览
• 市场驱动因素和限制因素简介
• 市场驱动力
  • 对健身设备的需求不断扩大
  • 增加诊断支出
  • 健康问题日益严重
• 市场製约因素
  • 系统成本高
  • 长期使用带来的安全问题
• 行业吸引力 - 波特五力分析
  • 新进入者的威胁
  • 买方/消费者议价能力
  • 供应商的议价能力
  • 替代品的威胁
  • 竞争公司之间的敌对关係

第 5 章技术快照

第 6 章市场细分

• 按类型
  • 有线
  • 无线
• 按传感器类型
  • 温度
  • 压力
  • 图像传感器
  • 生化传感器
  • 惯性传感器
  • 运动传感器
  • 心电图 (ECG)
  • 其他传感器
• 按行业
  • 医药
  • 医疗保健
  • 其他行业
• 按地区
  • 北美
    • 美国
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 其他欧洲地区
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 其他亚太地区
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 墨西哥
    • 其他拉丁美洲地区
  • 中东和非洲
    • 阿联酋
    • 沙特阿拉伯
    • 以色列
    • 其他中东地区

第七章竞争格局

• 公司简介
  • GE Healthcare
  • Honeywell International Inc.
  • Stmicroelectronics N.V.
  • First Sensor AG
  • Medtronic PLC
  • Smiths Medical
  • Measurement Specialties, Inc.
  • Analog Devices, Inc.
  • Texas Instruments
  • NXP Semiconductor N.V.
  • LumaSense Technologies
  • Zephyr Technology Corp.
  • Nonin Medical Inc.
  • Innovative Sensor Technology USA

第八章投资分析

第九章市场机会与未来趋势

The biomedical sensors market was valued at USD 10.79 billion in 2020 and expected to reach USD 15.13 billion by 2026 and grow at a CAGR of 6% over the forecast period (2021 - 2026). Technological advancements in the field of biomedical sensors using microtechnology and nanotechnology are expected to bring tiny, robust, smart and cost-effective sensors that are adaptable to the individual genetic formulation. These sensors can be set to trigger alerts when they enlist unpredictable readings, screen the existence of toxic agents in the blood, or empower drug directly into the circulatory system. Investments in developing sensors with such capabilities will act as a significant factor for the growth of the market and eventually, these products are expected to have a huge demand in the healthcare industry.

Key Highlights

• Increased demand for patient monitoring applications, technological innovations in MEMS enabling the design of low-cost, high-performance sensors, that can be easily integrated into other applications is some of the key drivers for the growth of the market. Further, the increased incidence of lifestyle based diseases, a growing proportion of the aging population and new forms of diseases have also played a significant role in market growth for biomedical sensors globally.
• Emerging applications for biomedical sensors in the field of nanotechnology and continual innovations leading to the development of innovative non-invasive sensor-based medical applications will open up several growth opportunities in this market. However, security concerns related to the use of biomedical sensors, long product development cycles and stringent regulatory procedures required for operating in the medical sector remain major challenges impeding growth in the overall market.
• Even though biomedical sensors are playing a major role in life-saving situations, the market faces certain challenges such as patient's safety and comfort due to strong electromagnetic fields, transferring energy from external to internal parts with high efficiency and high data rates, limited computation and data storage, and ultra-low power consumption.

Key Market Trends

Healthcare Industry Holds a Substantial Share of Biomedical Sensors Market

• Recently, many healthcare researchers are increasingly focusing on early detection and prevention of illnesses. Infectious diseases are becoming the leading cause of death, especially for people in developing countries, and early detection and accurate diagnosis of these diseases is turning out to be a vital factor driving the market for biomedical sensors.
• Accelerometers are used for measuring heart rate, blood pressure, and levels of glucose and oxygen in the blood. These sensors have major applications in devices such as defibrillators and pacemakers. Hence, the growing awareness concerning healthcare has increased the need for sensor technologies and monitoring devices that are able to sense and provide feedback to the users about the health status for increased safety.
• Medical sensors in healthcare have the capability to bring about a revolution concerning the way a disease is cured or prevented. Advances in engineering, technology, and material sciences have given away for highly sophisticated sensors that can be used in medical research. These kinds of sensors open doors for innovation and may someday lead to thought-controlled prosthetics and other personal assistive devices for people with paralysis, amputated limbs and other movement impairments driving the market.

North America Dominates the Global Biosensor Market

• North America is the chief revenue contributor for the biomedical sensor market and is estimated to grow rapidly, owing to the big number of vendors of medical sensors. The chief driving factors for the growth in this market are quickly ageing population and growth of the home healthcare market in North America.
• The Americas ruled the global market in 2018, which is credited to the availability of advanced health care infrastructure in the region and the extraordinary consumption of medical devices. There is a huge scope for expansion of innovative healthcare products due to the convergence of sensors, digital apps, and wireless technologies, demonstrated by the rising number of smartphone and tablet users.
• A large number of businesses are spending in research in these products and augmented funding from government agencies is probably to result in the launch of advanced and innovative biomedical sensors like wearable and implantable sensors in the biomedical sensor market in the future in North America. Also, the growing rate of smartphone usage is powering the market growth in the North America region and the U.S. is ruling the market.

Competitive Landscape

The biomedical sensors market is highly competitive and consists of several major players. In terms of market share, few of the major players currently dominate the market. These major players with a prominent share in the market are focusing on expanding their customer base across foreign countries. Rising disposable income, rising awareness about devices with sensors and growing customer base across the world have led to vast growth opportunities for players in this market. These players are leveraging on strategic collaborative initiatives to increase their market share and increase their profitability.

• February 2019 - Texas Instruments (TI) announced today new bulk acoustic wave (BAW)-based embedded processing and analogue chips for the next generation of connectivity and communications infrastructure. The first two devices developed with TI BAW technology, the SimpleLink CC2652RB wireless microcontroller (MCU) and the LMK05318 network synchronizer clock will help system designers streamline design logistics for faster time to market, while enabling stable, simplified and high-performance data delivery, which in return, allows for potential overall development and system cost savings.

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 Study Deliverables
• 1.2 Study Assumptions
• 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

• 4.1 Market Overview
• 4.2 Introduction to Market Drivers and Restraints
• 4.3 Market Drivers
  • 4.3.1 Growing Demand for Fitness Devices
  • 4.3.2 Increasing Spendings on Diagnostics
  • 4.3.3 Rising Health Concerns
• 4.4 Market Restraints
  • 4.4.1 High Costs of the Systems
  • 4.4.2 Safety Issues Related to Prolonged Usage
• 4.5 Industry Attractiveness - Porter's Five Force Analysis
  • 4.5.1 Threat of New Entrants
  • 4.5.2 Bargaining Power of Buyers/Consumers
  • 4.5.3 Bargaining Power of Suppliers
  • 4.5.4 Threat of Substitute Products
  • 4.5.5 Intensity of Competitive Rivalry

5 TECHNOLOGY SNAPSHOT

6 MARKET SEGMENTATION

• 6.1 By Type
  • 6.1.1 Wired
  • 6.1.2 Wireless
• 6.2 By Sensor Type
  • 6.2.1 Temperature
  • 6.2.2 Pressure
  • 6.2.3 Image Sensors
  • 6.2.4 Biochemical
  • 6.2.5 Inertial Sensors
  • 6.2.6 Motion Sensors
  • 6.2.7 Electrocardiogram (ECG)
  • 6.2.8 Other Sensor Types
• 6.3 By Industry
  • 6.3.1 Pharmaceutical
  • 6.3.2 Healthcare
  • 6.3.3 Other Industry Types
• 6.4 Geography
  • 6.4.1 North America
    • 6.4.1.1 US
    • 6.4.1.2 Canada
  • 6.4.2 Europe
    • 6.4.2.1 United Kingdom
    • 6.4.2.2 Germany
    • 6.4.2.3 France
    • 6.4.2.4 Rest of Europe
  • 6.4.3 Asia Pacific
    • 6.4.3.1 China
    • 6.4.3.2 India
    • 6.4.3.3 Japan
    • 6.4.3.4 Rest of Asia-Pacific
  • 6.4.4 Latin America
    • 6.4.4.1 Brazil
    • 6.4.4.2 Argentina
    • 6.4.4.3 Mexico
    • 6.4.4.4 Rest of Latin America
  • 6.4.5 Middle East & Africa
    • 6.4.5.1 UAE
    • 6.4.5.2 Saudi Arabia
    • 6.4.5.3 Israel
    • 6.4.5.4 Rest of Middle East & Africa

7 COMPETITIVE LANDSCAPE

• 7.1 Company Profiles
  • 7.1.1 GE Healthcare
  • 7.1.2 Honeywell International Inc.
  • 7.1.3 Stmicroelectronics N.V.
  • 7.1.4 First Sensor AG
  • 7.1.5 Medtronic PLC
  • 7.1.6 Smiths Medical
  • 7.1.7 Measurement Specialties, Inc.
  • 7.1.8 Analog Devices, Inc.
  • 7.1.9 Texas Instruments
  • 7.1.10 NXP Semiconductor N.V.
  • 7.1.11 LumaSense Technologies
  • 7.1.12 Zephyr Technology Corp.
  • 7.1.13 Nonin Medical Inc.
  • 7.1.14 Innovative Sensor Technology USA

8 INVESTMENT ANALYSIS

9 MARKET OPPORTUNITIES AND FUTURE TRENDS